Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hao-Yang Xin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|June 16, 2019
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resectionZheng-Jun Zhou, Hao-Yang Xin, Jia Li, et al.
Cancer Cell International|December 9, 2020
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resectionZhi-Qiang Hu, Zheng-Jun Zhou, Chu-Bin Luo, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2020
Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinomaZhi-Qiang Hu, Hao-Yang Xin, Chu-Bin Luo, et al.
NPJ Genomic Medicine|April 8, 2020
MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signalingZheng-Jun Zhou, Chu-Bin Luo, Hao-Yang Xin, et al.
Hepatology (Baltimore, Md.)|September 20, 2021
Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinomaShao-Lai Zhou, Chu-Bin Luo, Cheng-Li Song, et al.
JAMA Surgery|November 3, 2021
Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic CholangiocarcinomaShao-Lai Zhou, Hao-Yang Xin, Rong-Qi Sun, et al.
Clinical and Translational Medicine|May 28, 2021
LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2Dan Yin, Zhi-Qiang Hu, Chu-Bin Luo, et al.
Hepatology (Baltimore, Md.)|December 16, 2019
Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma MetastasisZhi-Qiang Hu, Shao-Lai Zhou, Jia Li, et al.
JAMA Network Open|March 3, 2023
Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic CholangiocarcinomaHao-Yang Xin, Rong-Qi Sun, Ji-Xue Zou, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma ProgressionShao-Lai Zhou, Dan Yin, Zhi-Qiang Hu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|June 16, 2019
Intratumoral plasmacytoid dendritic cells as a poor prognostic factor for hepatocellular carcinoma following curative resectionZheng-Jun Zhou, Hao-Yang Xin, Jia Li, et al.
Cancer Cell International|December 9, 2020
Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resectionZhi-Qiang Hu, Zheng-Jun Zhou, Chu-Bin Luo, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2020
Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinomaZhi-Qiang Hu, Hao-Yang Xin, Chu-Bin Luo, et al.
NPJ Genomic Medicine|April 8, 2020
MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signalingZheng-Jun Zhou, Chu-Bin Luo, Hao-Yang Xin, et al.
Hepatology (Baltimore, Md.)|September 20, 2021
Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinomaShao-Lai Zhou, Chu-Bin Luo, Cheng-Li Song, et al.
JAMA Surgery|November 3, 2021
Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic CholangiocarcinomaShao-Lai Zhou, Hao-Yang Xin, Rong-Qi Sun, et al.
Clinical and Translational Medicine|May 28, 2021
LINC01133 promotes hepatocellular carcinoma progression by sponging miR-199a-5p and activating annexin A2Dan Yin, Zhi-Qiang Hu, Chu-Bin Luo, et al.
Hepatology (Baltimore, Md.)|December 16, 2019
Circular RNA Sequencing Identifies CircASAP1 as a Key Regulator in Hepatocellular Carcinoma MetastasisZhi-Qiang Hu, Shao-Lai Zhou, Jia Li, et al.
JAMA Network Open|March 3, 2023
Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic CholangiocarcinomaHao-Yang Xin, Rong-Qi Sun, Ji-Xue Zou, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma ProgressionShao-Lai Zhou, Dan Yin, Zhi-Qiang Hu, et al.
Pageof 2